Therefore, eEF2K is a negative regulator of protein synthesis (Wang et al., 2017), and inhibition of eEF2K activity may have therapeutic significance in preventing the survival of tumor cells and recovering protein translation. This evidence concerns the gene EEF2K and neoplasm.